The method for determination of serum lipid-free apolipoprotein concentration and its clinical application
The method for determination of serum lipid-free apolipoprotein concentration and its clinical application
批准号:
11557204
负责人:
SEISHIMA Mitsuru
金额:
$6.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001
中文摘要
已知HDL在颗粒大小上是不均匀的,并且小HDL颗粒比大HDL颗粒更有效地促进胆固醇从细胞膜流出。小分子HDL的检测采用双向凝胶电泳法,但该方法耗时较长。本研究采用高效液相色谱法分离载脂蛋白A-I,洗脱时间为51 ~ 56 min,由于在ELISA系统中使用了载脂蛋白A-I的抗体,因此,载脂蛋白A-I的表位与HDL的表位相同。我们将50 U/ml的trasyrol加入血液中,并通过HPLC加入500 μ1的分级溶液中。反复冻融实验可使血清载脂蛋白A-I浓度增加2倍,即使在4℃冻存条件下,血清载脂蛋白A-I浓度也随时间变化。因此,血清样品立即进行HPLC处理或在-80℃下冷冻备用。与健康对照组相比,男性和女性冠心病患者的血清无脂质apo A-I浓度显著增加。这些发现表明,胆固醇逆向转运在冠心病中改变,无脂质载脂蛋白A-I的测量可能是动脉粥样硬化的良好标志物。
英文摘要
It is known that HDL are heterogeneous in particle size and small HDL particle can promote more effectively cholesterol efflux from cell membrane than large HDL particle. Small HDL are detected by two-dimentional gel electrophoresis, but this method is time consuming. Lipid-free apo A-I in this study was separated by HPLC and was elutred from 51 min to 56 min. The epitope of lipid-free apo A-I is the same as tjhat of a HDL, because we used the antibody to apo A-I in the ELISA system. We added SOU/ml of trasyrol to blood and also to 500 μ1 of fractionated solutions by HPLC. Serum lipid-free apo A-I concentration increased two times by repeated freeze and thawing test and changed with time even in the store at 4℃. Thus, serum sample was immediately treated for HPLC or freezed at -80℃ until use.Serum lipid-free apo A-I concentrations significantly increased in patients with coronary heart disease compared to healthy controls in both males and females. These findings show that reverse cholesterol transport is altered in coronary heat disease and the measurement of lipid-free apo A-I may be a good marker for atherosclerosis.
期刊论文(45)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
清島 満, 他: "高脂血症(上巻)リポ蛋白X"日本臨床.
Mitsuru Kiyoshima 等:“高脂血症(第 1 卷)脂蛋白 X”日本临床。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
藤井秀比古 他: "医学のあゆみ「サイトカインと疾患」"医歯薬出版. 222 (2000)
Hidehiko Fujii 等:“医学史:细胞因子和疾病”Ishiyaku Publishing 222(2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
浦上克哉 他: "髄液中アポA-IおよびE"日本臨床. 57. 158-161 (1999)
Katsuya Urakami 等人:“脑脊液中的 ApoA-I 和 E”日本临床杂志 57. 158-161 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fei H, et al.: "Evaluation of two different homogeneous assays for LDL-cholesterol in lipoprotein-X-positive serum"Clin. Chem.. 46・9. 1351-1356 (2000)
Fei H 等人:“脂蛋白 X 阳性血清中 LDL-胆固醇的两种不同均相测定的评估”Clin. 1351-1356 (2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
清島満: "Total cholesterol(T-CHO)の基準値について"クリニシアン. 46. 691-693 (1999)
Mitsuru Kiyoshima:“关于总胆固醇(T-CHO)的标准值”临床医生46. 691-693(1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 30 条
The role of IDO in the HBV-related liver diseases.
-
批准号:24659361
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2012
-
负责人:SEISHIMA Mitsuru
-
依托单位:
Screening and gene analysis for the protection from muscle damage by statin drugs
-
批准号:21390179
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2009
-
负责人:SEISHIMA Mitsuru
-
依托单位:
Study on analytical system for the etiology of autoimmune disease using two-dimensional nano LC/MS
-
批准号:17390161
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.93万
-
财政年份:2005
-
负责人:SEISHIMA Mitsuru
-
依托单位:
Study on the mechanism of atherosclerotic lesion formation using cytokine-knockout mouse
-
批准号:13470517
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.7万
-
财政年份:2001
-
负责人:SEISHIMA Mitsuru
-
依托单位:
The mechanism for synthesis and secretion of apo A-IV in CaCo-2 cells
-
批准号:09672353
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1997
-
负责人:SEISHIMA Mitsuru
-
依托单位:
Study on apo A-IV polymorphism in patients with hyperlipidemia.
-
批准号:07672485
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1995
-
负责人:SEISHIMA Mitsuru
-
依托单位: